Filing Details

Accession Number:
0001144204-16-088987
Form Type:
4
Zero Holdings:
No
Publication Time:
2016-03-18 18:01:55
Reporting Period:
2016-03-16
Filing Date:
2016-03-18
Accepted Time:
2016-03-18 18:01:55
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1133869 Capricor Therapeutics Inc. CAPR Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1604726 Edward St. John, Llc 2560 Lord Baltimore Drive
Baltimore MD 21244
No No Yes No
1604736 A. Edward John St. 2560 Lord Baltimore Drive
Baltimore MD 21244
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2016-03-16 416,666 $2.40 842,439 No 4 P Direct
Common Stock Acquisiton 2016-03-16 416,666 $2.40 842,439 No 4 P Indirect By Edward St. John, LLC
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Indirect By Edward St. John, LLC
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Warrant Acquisiton 2016-03-16 208,333 $0.00 208,333 $4.50
Common Stock Warrant Acquisiton 2016-03-16 208,333 $0.00 208,333 $4.50
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
208,333 2016-09-17 2019-03-16 No 4 P Direct
208,333 2016-09-17 2019-03-16 No 4 P Indirect
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 1,556,141 Indirect By MD BTI, LLC
Common Stock 1,556,141 Indirect By MD BTI, LLC
Common Stock 54,602 Direct
Common Stock 324,196 Indirect By MD BTI, Inc.
Footnotes
  1. This Form 4 is filed jointly by Edward A. St. John and Edward St. John, LLC ("St. John LLC"). The shares and warrants reported here are owned directly by St. John LLC.
  2. St. John LLC entered into a Subscription Agreement with Capricor Therapeutics, Inc. (the "Issuer") pursuant to which St. John LLC, on March 16, 2016, purchased an aggregate of 416,666 shares of the Issuer's common stock at a purchase price of $2.40 per share for an aggregate purchase price of approximately US$1,000,000. In connection with the purchase of shares, St. John LLC also received a warrant to purchase up to 208,333 shares of the Issuer's common stock at a strike price of $4.50 per share, exercisable at any time between September 17, 2016 and March 16, 2019.
  3. The shares reported here are owned indirectly by St. John LLC.
  4. Mr. St. John is the sole member and general manager of St. John LLC. Accordingly, Mr. St. John is the indirect beneficial owner of the shares and warrants reported here. Mr. St. John disclaims beneficial ownership of these shares and warrants except to the extent of his pecuniary interest in the shares and warrants.
  5. The shares reported here are owned indirectly by Mr. St. John.
  6. The shares reported here are owned directly by Mr. St. John.
  7. Thee shares reported here are owned indirectly by Mr. St. John.